The Relationship Between Metabolites of Carotenoids, Vitamin A and Vitamin E Serum Levels and COVID-19 Disease Severity


Özpınar A. (Yürütücü), Serdar M. A., Serteser M., Kilercik M., Çetiner M.

Diğer Ülkelerden Üniversiteler Tarafından Desteklenmiş Proje, 2024 - 2025

  • Proje Türü: Diğer Ülkelerden Üniversiteler Tarafından Desteklenmiş Proje
  • Başlama Tarihi: Şubat 2024
  • Bitiş Tarihi: Mart 2025

Proje Özeti

Oxidative stress and inflammation play central roles in the immunopathogenesis of COVID-19.  In this study, the protective effects of carotenoids, retinol, and vitamin E as antioxidants and anti-inflammatory were investigated for their potential to distinguish COVID-19 and its severity. 44 COVID-19 patients, and 39 healthy controls categorized into three groups based on severity were analyzed. Carotenoids, vitamin E, vitamin A Retinol binding-protein 4 (RBP4) and transthyretin (TTR), total blood cells, clinical chemistry and inflammation markers were evaluated and statistically analyzed. Concentrations of γ-tocopherol, α-tocopherol, retinol, total vitamin A, lutein, total carotenoids, TTR, and inflammatory markers were significantly lower in COVID-19 patients compared to healthy controls. Multivariate regression analysis identified three independent parameters that effectively distinguished COVID-19 patients from healthy controls: RBP4/total vitamin A, γ-tocopherol and ferritin. This study shows that carotenoids, retinol and vitamin E were inadequate in distinguishing COVID-19 disease severity, however, along with the independent predictive values of the RBP4/total vitamin A ratio, γ-tocopherol, and ferritin, these antioxidants were significantly reduced in COVID-19 patients compared to the control group, thereby demonstrating their potential as reliable biomarkers for distinguishing COVID-19.